High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer
- PMID: 30533477
- PMCID: PMC6262224
- DOI: 10.1016/j.gore.2018.08.006
High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer
Figures
References
-
- Arima R., Marttila M., Hautakoski A., Arffman M., Sund R., Ilanne-Parikka P. Antidiabetic medication, statins and the risk and prognosis of endometrioid endometrial cancer in patients with type 2 diabetes. Gynecol. Oncol. 2017;146(3):636–641. - PubMed
-
- Ford E.S., Giles W.H., Mokdad A.H. Increasing Prevalence of the Metabolic Syndrome among U.S. adults. Diabetes Care. 2004;27(10):2444–2449. - PubMed
-
- Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–2752. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources